Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Drugging RNA Modifying Enzymes – METTL3 Inhibitors as a novel therapeutic strategy for Acute Myeloid Leukemia

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2374